← Dashboard
Stock
AUTL
AUTOLUS THERAPEUTICS PLCLatest close $1.804 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
4
27 funds tracked
Ever held
6
Current + past
New this quarter
1
Exited this quarter
0
Marquee-fund ownership over time
Aug 9, 2024Feb 14, 2025Nov 14, 2025May 15, 2026
Now
4
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $3.67 | $1.80 | -51% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $3.59 | $1.80 | -50% |
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $3.59 | $1.80 | -50% |
| Point72 Asset Management re-entered | Q1 2025(8Q snapshot) | 5Q | $2.04 | $1.80 | -12% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Two Sigma Investments | Q3 2024 | Q1 2026 | → $1.51 | -58% |
| D.E. Shaw | Q3 2024 | Q1 2025 | → $2.04 | -43% |
Fundamentals
XBRL · AUTOLUS THERAPEUTICS PLCAnnual figures sourced directly from AUTOLUS THERAPEUTICS PLC's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$75.39M
FY2025+500%+ YoY
Net income
-$287.53M
FY2025-30% YoY
EPS (diluted)
$-1.08
FY2025-26% YoY
Free cash flow(?)
-$302.61M
FY2025-33% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Autolus Therapeutics plc — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventJun 9, 2026
- 10-QQuarterly reportMay 14, 2026
- 8-KMaterial eventMay 14, 2026
- 8-KMaterial eventApr 29, 2026
- 8-KMaterial eventApr 16, 2026
- S-3Registration (shelf)Apr 13, 2026
- S-3Registration (shelf)Apr 13, 2026
- 8-KMaterial eventApr 8, 2026
- 10-KAnnual reportMar 27, 2026
- 8-KMaterial eventMar 27, 2026
- 8-KMaterial eventJan 26, 2026
- 8-KMaterial eventJan 12, 2026
- 8-KMaterial eventDec 2, 2025
- 10-QQuarterly reportNov 12, 2025
- 8-KMaterial eventNov 12, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q2 2026 | open | $1.63 | $1.80 | +10% |
| Point72 Asset Management | Q1 2026 | open | $1.51 | $1.80 | +19% |
| Millennium Management | Q4 2025 | Q1 2026 | $1.37 | $1.51 | +10% |
| Point72 Asset Management | Q1 2025 | Q4 2025 | $2.04 | $1.37 | -33% |
| Citadel Advisors | Q3 2024 | open | $3.59 | $1.80 | -50% |
| Two Sigma Investments | Q3 2024 | Q1 2026 | $3.59 | $1.51 | -58% |
| D.E. Shaw | Q3 2024 | Q1 2025 | $3.59 | $2.04 | -43% |
| Millennium Management | Q3 2024 | Q3 2025 | $3.59 | $1.85 | -48% |
| Renaissance Technologies | Q3 2024 | open | $3.67 | $1.80 | -51% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.